Cover Image
市場調查報告書

血小板減少性疾病:全球臨床實驗趨勢

Thrombocytopenia Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 235296
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
血小板減少性疾病:全球臨床實驗趨勢 Thrombocytopenia Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月30日 內容資訊: 英文 110 Pages
簡介

本報告提供血小板減少性疾病臨床實驗相關之最新趨勢分析,提供您各地區臨床實驗數量,臨床實驗各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 血小板減少性疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:血液疾病治療藥臨床實驗上血小板減少性疾病所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:血液疾病治療藥臨床實驗上血小板減少性疾病所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

血小板減少性疾病臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline Plc
    • Amgen Inc.
    • Eisai
    • F. Hoffmann-La Roche Ltd.
    • 鹽野義製藥
    • Pfizer Inc.
    • Octapharma AG
    • Baxter International Inc.
    • Rigel Pharmaceuticals, Inc.
    • Biogen, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Shandong University
    • Weill Cornell Medical College
    • Henri Mondor University Hospital
    • National Heart, Lung, and Blood Institute
    • University of California, San Francisco
    • Assistance Publique - Hopitaux de Paris
    • Boston Children's Hospital
    • Hospital Universitario "Dr. Jose E. Gonzalez"
    • New England Research Institutes
    • Peking University People's Hospital

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2750CTIDB

GlobalData's clinical trial report, "Thrombocytopenia Global Clinical Trials Review, H1, 2015" provides an overview of Thrombocytopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Thrombocytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Thrombocytopenia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Thrombocytopenia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Thrombocytopenia Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Thrombocytopenia
      • Jun 12, 2015: FDA Approves Promacta for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
      • Jun 10, 2015: CTI BioPharma And Baxter Announce Patient-Reported Outcomes (PROs) From Pacritinib Phase 3 In Patients With Myelofibrosis To Be Presented In Late-Breaking Session At EHA
      • May 27, 2015: Amgen To present data from Nplate study at the 20th Congress of the EHA
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Shionogi & Co., Ltd.
      • Clinical Trial Overview of Shionogi & Co., Ltd.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Octapharma AG
      • Clinical Trial Overview of Octapharma AG
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Rigel Pharmaceuticals, Inc.
      • Clinical Trial Overview of Rigel Pharmaceuticals, Inc.
      • Biogen, Inc.
      • Clinical Trial Overview of Biogen, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Shandong University
      • Clinical Trial Overview of Shandong University
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
      • Henri Mondor University Hospital
      • Clinical Trial Overview of Henri Mondor University Hospital
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Boston Children's Hospital
      • Clinical Trial Overview of Boston Children's Hospital
      • Hospital Universitario "Dr. Jose E. Gonzalez"
      • Clinical Trial Overview of Hospital Universitario "Dr. Jose E. Gonzalez"
      • New England Research Institutes
      • Clinical Trial Overview of New England Research Institutes
      • Peking University People's Hospital
      • Clinical Trial Overview of Peking University People's Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Thrombocytopenia Therapeutics, Global, Clinical Trials by Region, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
  • Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
  • Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Thrombocytopenia Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Thrombocytopenia Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Thrombocytopenia Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen, Inc., 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong University, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Henri Mondor University Hospital, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario "Dr. Jose E. Gonzalez", 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by New England Research Institutes, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking University People's Hospital, 2015*

List of Figures

  • Thrombocytopenia Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
  • Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Thrombocytopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Thrombocytopenia to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
  • Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Thrombocytopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Thrombocytopenia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Thrombocytopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top